Citations

Clear

4847 citation(s) found for "Yu, Eric".

Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
Lahrouchi, Najim , Crotti, Lia , Mizusawa, Yuka , Postema, Pieter G. , Beekman, Leander , Walsh, Roddy , Hasegawa, Kanae , Barc, Julien , Ernsting, Marko, Turkowski, Kari L. , Mazzanti, Andrea , Beckmann, Britt M., Diamant, Ulla‐Britt , Kucho, Yu, Robyns, Tomas , Winbo, Annika , Jabbari, Reza , Lubitz, Steven A., Steinfurt, Johannes , Rudic, Boris , Shoemaker, Moore B., Weeke, Peter , Davies, Brianna , Andorin, Antoine , Hofman, Nynke , Pedrazzini, Matteo , Tester, David J. , Bos, J. Martijn , Platonov, Pyotr G. , Stallmeyer, Birgit, Zumhagen, Sven, Nannenberg, Eline A., Veldink, Jan H., Berg, Leonard H. van den, Al‐Chalabi, Ammar , Shaw, Christopher E. , Shaw, Pamela J. , Morrison, Karen , Müller‐Nurasyid, Martina , Cusi, Daniele , Lathrop, Mark , Munter, Markus, Aung, Tin , Ozaki, Mineo , Lichtner, Peter , Tintelen, J. Peter van , Hoedemaekers, Yvonne M., Napolitano, Carlo , Gourraud, Jean‐Baptiste , Makiyama, Takeru , Ohno, Seiko , Itoh, Hideki , Roden, Dan M. , Saenen, Johan , Borggrefe, Martin, Odening, Katja E. , Ellinor, Patrick T., Tfelt‐Hansen, Jacob , Skinner, Jonathan R. , Berg, Maarten P. van den , Makita, Naomasa , Breckpot, Jeroen , Yoshinaga, Masao , Behr, Elijah R. , Rydberg, Annika , Aiba, Takeshi , Priori, Silvia G. , Newton‐Cheh, Christopher , Schulze‐Bahr, Eric , Horie, Minoru , Wilde, Arthur A.M. , Tanck, Michael W.T. , Bezzina, Connie R. , Lubitz, Steven A. , Crotti, Lia , Makita, Naomasa , Horie, Minoru , Behr, Elijah Raphael , van Tintelen, J Peter , Odening, Katja E , Bos, Johan M , Tanck, Michael , Barc, Julien , Tfelt-Hansen, Jacob , Skinner, Jonathan R , van den Berg, Maarten P , Robyns, Tomas , Lubitz, Steven A , Al-Chalabi, Ammar , Bezzina, Connie R , Gourraud, Jean-Baptiste , Mazzanti, Andrea , Postema, Pieter G , Priori, Silvia , Walsh, Roddy , Tadros, Rafik , Beckmann, Britt-Maria, Shimamoto, Keiko , Wijeyeratne, Yanushi D. , Ishikawa, Taisuke , Arbelo, Elena , Christiansen, Michael , Loeys, Bart , Pfeiffer, Ryan D. , Dagradi, Federica , Sarquella-Brugada, Georgia , Campuzano, Óscar , Berg, Leonard H. van den , Andersen, Peter Munch , Barlassina, Cristina , Galán, Pilar , Werge, Thomas Mears , Ribasés, Marta , Khor, Chiea Chuen , Meitinger, Thomas , Denjoy, Isabelle , Leenhardt, Antoine , Shimizu, Wataru , Schott, Jean‐Jacques , Ohno, Seiko , Krahn, Andrew D. , Antzelevitch, Charles , Roden, Dan M. , Ellinor, Patrick T. , Olesen, Morten S. , Brugada, Josép , Brugada, Ramón , Aiba, Takeshi , Kääb, Stefan , Guicheney, Pascale , Tan, Hanno L. , Ackerman, Michael , Schwartz, Peter J. , Probst, Vincent

Mayo Clinic

Circulation | May 20, 2020 | Volume: 142 | Issue: 4 | Pages: 324-338

10.1161/circulationaha.120.045956 | PMID 32429735 Get It

Background: Long QT syndrome (LQTS) is a rare genetic disorder and a major preventable cause of sudden cardiac death in the young. A causal rare genetic variant with large effect size is identified in up to 80% of probands (genotype positive) and cascade family screening shows incomplete penetrance of genetic variants. Furthermore, a proportion of cases meeting diagnostic criteria for LQTS remain genetically elusive despite genetic testing of established genes (genotype negative). These observations raise the possibility that common genetic variants with small effect size contribute to the clinical picture of LQTS. This study aimed to characterize and quantify the contribution of common genetic variation to LQTS disease susceptibility. Methods: We conducted genome-wide association studies followed by transethnic meta-analysis in 1656 unrelated patients with LQTS of European or Japanese ancestry and 9890 controls to identify susceptibility single nucleotide polymorphisms. We estimated the common variant heritability of LQTS and tested the genetic correlation between LQTS susceptibility and other cardiac traits. Furthermore, we tested the aggregate effect of the 68 single nucleotide polymorphisms previously associated with the QT-interval in the general population using a polygenic risk score. Results: Genome-wide association analysis identified 3 loci associated with LQTS at genome-wide statistical significance ( P <5×10 −8 ) near NOS1AP , KCNQ1 , and KLF12 , and 1 missense variant in KCNE1 (p.Asp85Asn) at the suggestive threshold ( P <10 −6 ). Heritability analyses showed that ≈15% of variance in overall LQTS susceptibility was attributable to common genetic variation ( h2SNP 0.148; standard error 0.019). LQTS susceptibility showed a strong genome-wide genetic correlation with the QT-interval in the general population (r g =0.40; P =3.2×10 −3 ). The polygenic risk score comprising common variants previously associated with the QT-interval in the general population was greater in LQTS cases compared with controls ( P <10−13), and it is notable that, among patients with LQTS, this polygenic risk score was greater in patients who were genotype negative compared with those who were genotype positive ( P <0.005). Conclusions: This work establishes an important role for common genetic variation in susceptibility to LQTS. We demonstrate overlap between genetic control of the QT-interval in the general population and genetic factors contributing to LQTS susceptibility. Using polygenic risk score analyses aggregating common genetic variants that modulate the QT-interval in the general population, we provide evidence for a polygenic architecture in genotype negative LQTS.
Modified acquisition strategy for reduced motion artifact in super resolution FSE multislice MRI: Application to prostate
Kargar, Soudabeh , Borisch, Eric A. , Froemming, Adam T. , Grimm, Roger C., King, Bernard F., Stinson, Eric G. , Riederer, Stephen J. , Kawashima, Akira

Mayo Clinic

Magnetic Resonance in Medicine | May 18, 2020 | Volume: 84 | Issue: 5 | Pages: 2537-2550

10.1002/mrm.28315 | PMID 32419197 Get It

PurposeTo reduce slice‐to‐slice motion effects in multislice ‐weighted fast‐spin‐echo ( FSE) imaging, manifest as “scalloping” in reformats, by modification of the acquisition strategy and to show applicability in prostate MRI.Methods FSE images of contiguous or overlapping slices are typically acquired using multiple passes in which each pass is comprised of multiple slices with slice‐to‐slice gaps. Combination of slices from all passes provides the desired sampling. For enhancement of through‐plane resolution with super resolution or for reformatting into other orientations, subtle ≈1 mm motion between passes can cause objectionable “scalloping” artifact. Here we address this by subdivision of each pass into multiple segments. Interleaving of segments from the multiple passes causes all slices to be acquired over substantially the same time, reducing pass‐to‐pass motion effects. This was implemented in acquiring 78 overlapped FSE axial slices and studied in phantoms and in 14 prostate MRI patients. Super‐resolution axial images and sagittal reformats from the original and new segmented acquisitions were evaluated by 3 uroradiologists.ResultsFor all criteria of sagittal reformats, the segmented acquisition was statistically superior to the original. For all sharpness criteria of axial images, although the trend preferred the original acquisition, the difference was not significant. For artifact in axial images, the segmented acquisition was significantly superior.ConclusionsFor prostate MRI the new segmented acquisition significantly reduces the scalloping motion artifact that can be present in reformats due to long time lags between the acquisition of adjacent or overlapped slices while retaining image sharpness in the acquired axial slices.
Refinement of the clinical and mutational spectrum of UBE2A deficiency syndrome
Cordeddu, Viviana , Macke, Erica L. , Radio, Francesca Clementina , Cicero, Stefania Lo , Pantaleoni, Francesca , Tatti, Massimo, Ciolfi, Andrea , Agolini, Emanuele , Bruselles, Alessandro , Brunetti‐Pierri, Nicola , Suri, Mohnish , Josephs, Katherine , McEntagart, Meriel , Lanpher, Brendan C. , Nickels, Katherine , Haworth, Andrea, Reed, Laura, Cappuccio, Gerarda , Mammi, Isabella, Tarnowski, Jessica M., Novelli, Antonio , Study, Deciphering Developmental Disorders, Melis, Daniela , Callewaert, Bert , Klee, Eric W. , Tartaglia, Marco , Agolini, Emanuele , Brunetti-Pierri, Nicola , Lanpher, Brendan, Cappuccio, Gerarda , Klee, Eric, Tartaglia, Marco , Callewaert, Bert , Radio, Francesca Clementina , Nickels, Katherine C , Bellacchio, Emanuele , Study, Deciphering Developmental Disorders, Dallapiccola, Bruno

Mayo Clinic

Clinical Genetics | May 16, 2020 | Volume: 98 | Issue: 2 | Pages: 172-178

10.1111/cge.13775 | PMID 32415735 Get It

AbstractUBE2A deficiency, that is, intellectual disability (ID) Nascimento type (MIM 300860), is an X‐linked syndrome characterized by developmental delay, moderate to severe ID, seizures, dysmorphisms, skin anomalies, and urogenital malformations. Forty affected subjects have been reported thus far, with 31 cases having intragenic UBE2A variants. Here, we report on additional eight affected subjects from seven unrelated families who were found to be hemizygous for previously unreported UBE2A missense variants (p.Glu62Lys, p.Arg95Cys, p.Thr99Ala, and p.Arg135Trp) or small in‐frame deletions (p.Val81_Ala83del, and p.Asp101del). A wide phenotypic spectrum was documented in these subjects, ranging from moderate ID associated with mild dysmorphisms to severe features including congenital heart defects (CHD), severe cognitive impairment, and pineal gland tumors. Four variants affected residues (Glu62, Arg95, Thr99 and Asp101) that contribute to stabilizing the structure of the E3 binding domain. The three‐residue in‐frame deletion, p.Val81_Ala83del, resulted from aberrant processing of the transcript. This variant and p.Arg135Trp mapped to regions of the protein located far from the E3 binding region, and caused variably accelerated protein degradation. By reviewing available clinical information, we revise the clinical and molecular profile of the disorder and document genotype‐phenotype correlations. Pineal gland cysts/tumors, CHD and hypogammaglobulinemia emerge as recurrent features.
Age Is Associated With Pain Experience and Opioid Use After Head and Neck Free Flap Reconstruction
Rettig, Eleni M. , Janus, Jeffrey R. , Moore, Eric J. , Glasgow, Amy E. , Marinelli, John P. , Habermann, Elizabeth B. , Abel, Kathryn M. Van , Glasgow, Amy E. , Marinelli, John P , Van Abel, Kathryn M , Habermann, Elizabeth , Glasgow, Amy E , Price, Daniel L.

Mayo Clinic

The Laryngoscope | May 16, 2020 | Volume: 130 | Issue: 8 | Pages: No page available

10.1002/lary.28713 | PMID 32413165 Get It

ObjectivesTo describe pain experience and opioid use after major head and neck reconstructive surgery.Study DesignRetrospective cohort study.MethodsPatients undergoing major head and neck surgery with microvascular free tissue transfer (free flaps) at a tertiary academic center were included. Pain scores (0–10) and demographic and clinical data were ascertained from medical records. Discharge opioid prescriptions and refills obtained within 30 days were recorded. Patient characteristics were compared with pain scores using nonparametric rank‐sum tests and with likelihood of refill using logistic regression models to calculate adjusted odds ratios (aORs) with 95% confidence intervals (CIs).ResultsThe study population comprised 445 patients. Median age was 60 years (interquartile range 50–68). Most patients had cancer (N = 350, 78%). The majority of free flaps were fibula (N = 153, 34%) or radial forearm (N = 159, 36%). Older patients reported significantly lower pain scores, whereas patients with opioid tolerance, anxiety, current smokers, and those undergoing larger volume resections or boney free flaps reported significantly higher pain scores. One‐quarter (N = 115, 26%) of patients obtained opioid refills. Patients aged ≥ 60 years had one‐half the odds of obtaining a refill compared with patients aged < 60 years (adjusted odds ratio [aOR] = 0.52, 95% confidence interval [CI] = 0.33–0.84), whereas surgical defect volume ≥ 100 cm3 (aOR = 1.92, 95% CI = 1.21–3.07) and higher pain score (aOR = 1.19, 95% CI = 1.07–1.32 per 1 point increase) increased the odds of refill.ConclusionContinued opioid use after discharge is common among patients undergoing major head and neck reconstruction, particularly for younger patients and after more extensive surgery. Older patients reported lower pain intensity and were less likely to obtain opioid refills, highlighting the wisdom of judicious opioid use for this vulnerable population.Level of EvidenceIV Laryngoscope, 130: E469–E478, 2020
Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice
Sherwood, Matthew W. , Piccini, Jonathan P. , Holmes, DaJuanicia N. , Pieper, Karen S. , Kowey, Peter R. , Mahaffey, Kenneth W. , Singer, Daniel E. , Ansell, Jack , Reiffel, James A. , Blanco, Rosalia , Steinberg, Benjamin A. , Fonarow, Gregg C. , Allen, Larry A. , Naccarelli, Gerald V. , Gersh, Bernard J. , Freeman, James V. , Chan, Paul S. , Peterson, Eric D. , Rao, Sunil V.

Mayo Clinic

Circulation: Cardiovascular Interventions | May 15, 2020 | Volume: 13 | Issue: 5 | Pages: No page available

10.1161/circinterventions.119.008274 | PMID 32408815 Get It

Background: Patients with atrial fibrillation on oral anticoagulation (OAC) undergoing cardiac catheterization face risks for embolic and bleeding events, yet information on strategies to mitigate these risks in contemporary practice is lacking. Methods: We aimed to describe the clinical/procedural characteristics of a contemporary cohort of patients with atrial fibrillation on OAC who underwent cardiac catheterization. Use of bleeding avoidance strategies and bridging therapy were described and outcomes including death, stroke, and major bleeding at 30 days and 1 year were compared by OAC type. Results: Of 13 404 patients in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II Registry from 2013 to 2016, 741 underwent cardiac catheterization (139 with percutaneous coronary intervention) in the setting of OAC. The patients’ median age was 71, 61.8% were male, white (87.2%), had hypertension (83.7%), hyperlipidemia (72.1%), diabetes mellitus (31.6%), and chronic kidney disease (28.2%); 20.2% received warfarin while 79.8% received direct acting oral anticoagulant. One third of patients underwent radial artery access, and bivalirudin was used in 4.6%. Bridging therapy was used more often in patients on warfarin versus direct acting oral anticoagulant (16.7% versus10.0%). OAC was interrupted in 93.8% of patients. Patients on warfarin versus direct acting oral anticoagulant were equally likely to restart OAC (58.0% versus 60.7%), had similar use of antiplatelet therapy (44.0% versus 41.3%) after catheterization, and had similar rates of myocardial infarction and death at 1 year, but higher rates of major bleeding (43.3 versus 12.9 events/100 patient years) and stroke (4.9 versus 1.9 events/100 patient years). Conclusions: In a real-world registry of patients with atrial fibrillation undergoing cardiac catheterization, most cases are elective, performed by femoral access, with interruption of OAC. Bleeding avoidance strategies such as radial artery access and bivalirudin were used infrequently and use of bridging therapy was uncommon. Nearly 40% of patients did not restart OAC postprocedure, exposing patients to risk for stroke. Further research is necessary to optimize the management of patients with atrial fibrillation undergoing cardiac catheterization.
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)
Al‐Naamani, Nadine , Krowka, Michael J. , Forde, Kimberly A. , Feng, Rui , Dweik, Raed A. , Bartolome, Sonja, Bull, Todd , Patel, Mamta, Oh, Jae K. , Lin, Grace , Doyle, Margaret F. , Denver, Nina, Andrew, Ruth , Fallon, Michael B. , Group, , for the Pulmonary Vascular Complications of Liver Disease Study, Al-Naamani, Nadine , Krok, Karen , Feng, Rui, Heresi, Gustavo A. , Roberts, Kari E. , Austin, Eric , Hemnes, Anna R. , MacLean, Margaret R. , Kawut, Steven M. , Group, , for the Pulmonary Vascular Complications of Liver Disease Study

Mayo Clinic

Hepatology | May 14, 2020 | Volume: 73 | Issue: 2 | Pages: 726-737

10.1002/hep.31314 | PMID 32407592 Get It

Background and Aims Portopulmonary hypertension (POPH) was previously associated with a single‐nucleotide polymorphism (SNP) rs7175922 in aromatase (cytochrome P450 family 19 subfamily A member 1 [CYP19A1]). We sought to determine whether genetic variants and metabolites in the estrogen signaling pathway are associated with POPH. Approach and Results We performed a multicenter case‐control study. POPH patients had mean pulmonary artery pressure >25 mm Hg, pulmonary vascular resistance >240 dyn‐sec/cm−5, and pulmonary artery wedge pressure ≤15 mm Hg without another cause of pulmonary hypertension. Controls had advanced liver disease, right ventricular (RV) systolic pressure <40 mm Hg, and normal RV function by echocardiography. We genotyped three SNPs in CYP19A1 and CYP1B1 using TaqMan and imputed SNPs in estrogen receptor 1 using genome‐wide markers. Estrogen metabolites were measured in blood and urine samples. There were 37 patients with POPH and 290 controls. Mean age was 57 years, and 36% were female. The risk allele A in rs7175922 (CYP19A1) was significantly associated with higher levels of estradiol (P = 0.02) and an increased risk of POPH (odds ratio [OR], 2.36; 95% confidence interval [CI], 1.12‐4.91; P = 0.02) whereas other SNPs were not. Lower urinary 2‐hydroxyestrogen/16‐α‐hydroxyestrone (OR per 1‐ln decrease = 2.04; 95% CI, 1.16‐3.57; P = 0.01), lower plasma levels of dehydroepiandrosterone‐sulfate (OR per 1‐ln decrease = 2.38; 95% CI, 1.56‐3.85; P < 0.001), and higher plasma levels of 16‐α‐hydroxyestradiol (OR per 1‐ln increase = 2.16; 95% CI, 1.61‐2.98; P < 0.001) were associated with POPH. Conclusions Genetic variation in aromatase and changes in estrogen metabolites were associated with POPH.
Understanding the Return of Genomic Sequencing Results Process: Content Review of Participant Summary Letters in the eMERGE Research Network
Lynch, John , Sharp, Richard R. , Aufox, Sharon , Bland, Harris T. , Zawatsky, Carrie L. Blout , Buchanan, Adam H. , Halverson, Colin , Harr, Margaret , Hebbring, Scott J. , Hoell, Christin , Holm, Ingrid A. , Jarvik, Gail P. , Kullo, Iftikhar, Kochan, David C., Lazzeri, Amanda L., Leppig, Kathleen A. , Madden, Jill A. , Marasà, Maddalena , Myers, Melanie F. , Peterson, Josh F. , Prows, Cynthia A. , Ralston, James D. , Rasouly, Hila Milo , Scrol, Aaron, Smith, Maureen E. , Stuttgen, Kelsey , Wiesner, Georgia L. , Wynn, Julia , Williams, Janet L. , Lynch, John A , Bland, Sarah T , Holm, Ingrid A , Milo Rasouly, Hila , Smith, Maureen E , Williams, Janet L , Myers, Melanie F , Sharp, Richard R , Jarvik, Gail P , Peterson, Josh F , Marasa, Maddalena , Hoell, Christin , Bowen, Deborah J. , Henrikson, Nora B. , Larson, Eric B. , Rahm, Alanna Kulchak , Sturm, Amy C. , Williams, Marc S

Mayo Clinic

Journal of Personalized Medicine | May 14, 2020 | Volume: 10 | Issue: 2 | Pages: 38

10.3390/jpm10020038 | PMID 32413979 Get It

A challenge in returning genomic test results to research participants is how best to communicate complex and clinically nuanced findings to participants in a manner that is scalable to the large numbers of participants enrolled. The purpose of this study was to examine the features of genetic results letters produced at each Electronic Medical Records and Genomics (eMERGE3) Network site to assess their readability and content. Letters were collected from each site, and a qualitative analysis of letter content and a quantitative analysis of readability statistics were performed. Because letters were produced independently at each eMERGE site, significant heterogeneity in readability and content was found. The content of letters varied widely from a baseline of notifying participants that results existed to more detailed information about positive or negative results, as well as materials for sharing with family members. Most letters were significantly above the Centers for Disease Control-suggested reading level for health communication. While continued effort should be applied to make letters easier to understand, the ongoing challenge of explaining complex genomic information, the implications of negative test results, and the uncertainty that comes with some types of test and result makes simplifying letter text challenging.
Orthopaedic Documentation and Coding Primer for Telemedicine and Electronic Patient Communication for the COVID-19 Pandemic
Hinckley, Nathaniel B. , Henley, M. Bradford , McIntyre, Louis F. , Stiefel, Eric C. , Davidson, James , Chhabra, Anikar , McIntyre, Louis , Stiefel, Eric , Chhabra, Anikar

Mayo Clinic

Journal of Bone and Joint Surgery | May 13, 2020 | Volume: 102 | Issue: 13 | Pages: 1105-1108

10.2106/jbjs.20.00649 | PMID 32618907 Get It

➢ The coronavirus disease 2019 (COVID-19) crisis has disrupted health care in the United States and globally, and the ability to treat patients as we did in the prepandemic environment has changed. The safety of patients and providers, the avoidance of unnecessary exposure, and the cancellation of elective procedures have prompted the use of telemedicine. In addition, many large institutions are without a functioning videoconferencing platform and the use of telephone visits has become essential. ➢ Several important changes have been made by the Centers for Medicare & Medicaid Services to facilitate ease of access to telemedicine during the COVID-19 pandemic, including alternate place of service codes, visit time associated with evaluation and management services, and new Current Procedural Terminology codes for virtual visits with new patients. ➢ Although telemedicine visits do not allow for a hands-on physical examination, it is prudent for the medical provider to understand and learn the breadth of examination that may take place through an audio and video (when possible)-enabled virtual visit.
Impact of central review of imaging in an FDG-PET response adapted Pediatric Hodgkin lymphoma protocol
Hoppe, BS, Castellino, S, Kessel, Sandy, Voss, Stephan D. , Mhlanga, Joyce , Lai, Hollie , Eutsler, Eric P., Keller, FG, Kelly, KM, Cho, S, McCarten, Kathleen M. , Castellino, Sharon M. , Alazraki, Adina

Mayo Clinic

Klinische Pädiatrie | May 11, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0040-1701938 Get It

Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study
Kerur, Basavaraj , Benchimol, Eric I. , Fiedler, Karoline , Stahl, Marisa G. , Hyams, Jeffrey S. , Stephens, Michael C., Lu, Ying , Pfefferkorn, Marian, Alkhouri, Raza, Strople, Jennifer , Kelsen, Judith R. , Siebold, Leah, Goyal, Alka , Rosh, Joel R. , LeLeiko, Neal S. , Limbergen, Johan Van , Guerrerio, Anthony L. , Maltz, Ross , Karam, Lina , Crowley, Eileen , Heyman, Melvin B. , Benkov, Keith , Noe, Joshua D. , Mouton, Dedrick, Pappa, Helen, Galanko, Joseph A. , Muise, Aleixo M. , Stephens, Michael, Leleiko, Neal S , Griffiths, Anne Marie , Deneau, Mark , Snapper, Scott B. , Kappelman, Michael D.

Mayo Clinic

Inflammatory Bowel Diseases | May 9, 2020 | Volume: 27 | Issue: 3 | Pages: 295-302

10.1093/ibd/izaa080 | PMID 32386060 Get It

Abstract Background The incidence of very early onset inflammatory bowel disease (VEOIBD) is increasing, yet the phenotype and natural history of VEOIBD are not well described. Methods We performed a retrospective cohort study of patients diagnosed with VEOIBD (6 years of age and younger) between 2008 and 2013 at 25 North American centers. Eligible patients at each center were randomly selected for chart review. We abstracted data at diagnosis and at 1, 3, and 5 years after diagnosis. We compared the clinical features and outcomes with VEOIBD diagnosed younger than 3 years of age with children diagnosed with VEOIBD at age 3 to 6 years. Results The study population included 269 children (105 [39%] Crohn’s disease, 106 [39%] ulcerative colitis, and 58 [22%] IBD unclassified). The median age of diagnosis was 4.2 years (interquartile range 2.9–5.2). Most (94%) Crohn’s disease patients had inflammatory disease behavior (B1). Isolated colitis (L2) was the most common disease location (70% of children diagnosed younger than 3 years vs 43% of children diagnosed 3 years and older; P = 0.10). By the end of follow-up, stricturing/penetrating occurred in 7 (6.6%) children. The risk of any bowel surgery in Crohn’s disease was 3% by 1 year, 12% by 3 years, and 15% by 5 years and did not differ by age at diagnosis. Most ulcerative colitis patients had pancolitis (57% of children diagnosed younger than 3 years vs 45% of children diagnosed 3 years and older; P = 0.18). The risk of colectomy in ulcerative colitis/IBD unclassified was 0% by 1 year, 3% by 3 years, and 14% by 5 years and did not differ by age of diagnosis. Conclusions Very early onset inflammatory bowel disease has a distinct phenotype with predominantly colonic involvement and infrequent stricturing/penetrating disease. The cumulative risk of bowel surgery in children with VEOIBD was approximately 14%–15% by 5 years. These data can be used to provide anticipatory guidance in this emerging patient population.